Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 332

1.

HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death.

Kingkaew N, Sangtong B, Amnuaiphon W, Jongpaibulpatana J, Mankatittham W, Akksilp S, Sirinak C, Nateniyom S, Burapat C, Kittikraisak W, Monkongdee P, Varma JK.

Int J Infect Dis. 2009 Nov;13(6):722-9. doi: 10.1016/j.ijid.2008.11.013. Epub 2009 Feb 4.

2.

Characteristics of HIV-infected tuberculosis patients in Thailand.

Mankatittham W, Likanonsakul S, Thawornwan U, Kongsanan P, Kittikraisak W, Burapat C, Akksilp S, Sattayawuthipong W, Srinak C, Nateniyom S, Tasaneeyapan T, Varma JK.

Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):93-103.

PMID:
19323040
3.

HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study.

Varma JK, Nateniyom S, Akksilp S, Mankatittham W, Sirinak C, Sattayawuthipong W, Burapat C, Kittikraisak W, Monkongdee P, Cain KP, Wells CD, Tappero JW.

BMC Infect Dis. 2009 Apr 13;9:42. doi: 10.1186/1471-2334-9-42.

4.

Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy.

Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):42-6.

PMID:
16885778
5.

Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand.

Sirinak C, Kittikraisak W, Pinjeesekikul D, Charusuntonsri P, Luanloed P, Srisuwanvilai LO, Nateniyom S, Akksilp S, Likanonsakul S, Sattayawuthipong W, Burapat C, Varma JK.

BMC Public Health. 2008 Jul 18;8:245. doi: 10.1186/1471-2458-8-245.

6.

Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.

Manosuthi W, Kiertiburanakul S, Phoorisri T, Sungkanuparph S.

J Infect. 2006 Dec;53(6):357-63. Epub 2006 Feb 17.

PMID:
16487593
7.

Causes of death in HIV-infected persons who have tuberculosis, Thailand.

Cain KP, Anekthananon T, Burapat C, Akksilp S, Mankhatitham W, Srinak C, Nateniyom S, Sattayawuthipong W, Tasaneeyapan T, Varma JK.

Emerg Infect Dis. 2009 Feb;15(2):258-64.

8.

Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.

Hung CC, Chen MY, Hsiao CF, Hsieh SM, Sheng WH, Chang SC.

AIDS. 2003 Dec 5;17(18):2615-22.

PMID:
14685055
9.

Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis.

Whalen C, Horsburgh CR Jr, Hom D, Lahart C, Simberkoff M, Ellner J.

AIDS. 1997 Mar 15;11(4):455-60.

PMID:
9084792
10.

Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy.

Girardi E, Palmieri F, Cingolani A, Ammassari A, Petrosillo N, Gillini L, Zinzi D, De Luca A, Antinori A, Ippolito G.

J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):326-31.

PMID:
11317073
11.

Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Côte d'Ivoire.

Mukadi YD, Wiktor SZ, Coulibaly IM, Coulibaly D, Mbengue A, Folquet AM, Ackah A, Sassan-Morokro M, Bonnard D, Maurice C, Nolan C, Kreiss JK, Greenberg AE.

AIDS. 1997 Jul 15;11(9):1151-8.

PMID:
9233463
12.

Outcome of HIV infected children with culture confirmed tuberculosis.

Hesseling AC, Westra AE, Werschkull H, Donald PR, Beyers N, Hussey GD, El-Sadr W, Schaaf HS.

Arch Dis Child. 2005 Nov;90(11):1171-4. Epub 2005 Jun 17.

13.

Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi.

Zachariah R, Spielmann MP, Chinji C, Gomani P, Arendt V, Hargreaves NJ, Salaniponi FM, Harries AD.

AIDS. 2003 May 2;17(7):1053-61.

PMID:
12700456
14.

Clinical forms and outcome of tuberculosis in HIV-infected patients in a tertiary hospital in São Paulo - Brazil.

Klautau GB, Kuschnaroff TM.

Braz J Infect Dis. 2005 Dec;9(6):464-78. Epub 2006 Jan 9.

15.

Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis.

Velasco M, Castilla V, Sanz J, Gaspar G, Condes E, Barros C, Cervero M, Torres R, Guijarro C; COMESEM Cohort.

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):148-52. doi: 10.1097/QAI.0b013e31819367e7.

PMID:
19131895
16.

Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India.

Raizada N, Chauhan LS, Babu BS, Thakur R, Khera A, Wares DF, Sahu S, Bachani D, Rewari BB, Dewan PK.

PLoS One. 2009 Jun 22;4(6):e5999. doi: 10.1371/journal.pone.0005999.

17.

The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.

Braitstein P, Nyandiko W, Vreeman R, Wools-Kaloustian K, Sang E, Musick B, Sidle J, Yiannoutsos C, Ayaya S, Carter EJ.

Pediatr Infect Dis J. 2009 Jul;28(7):626-32. doi: 10.1097/INF.0b013e31819665c5.

PMID:
19451858
18.

Clinical presentation and survival of smear-positive pulmonary tuberculosis patients of a university general hospital in a developing country.

Carvalho AC, Nunes ZB, Martins M, Araújo RO, Comelli M, Marinoni A, Kritski AL.

Mem Inst Oswaldo Cruz. 2002 Dec;97(8):1225-30. Epub 2003 Jan 20.

19.

Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi.

Mwaungulu FB, Floyd S, Crampin AC, Kasimba S, Malema S, Kanyongoloka H, Harries AD, Glynn JR, Fine PE.

Bull World Health Organ. 2004 May;82(5):354-63.

20.

Impact of a public antiretroviral program on TB/HIV mortality: Banteay Meanchey, Cambodia.

Eng B, Cain KP, Nong K, Chhum V, Sin E, Roeun S, Kim S, Keo S, Heller TA, Varma JK.

Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):89-92.

PMID:
19323039

Supplemental Content

Support Center